---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-034181"
form_type: "8-K"
ticker: "VIVS"
cik: "0001497253"
company_name: "VivoSim Labs, INC."
filed_at: "2025-03-06T23:59:59+00:00"
generated_at: "2026-05-25T05:49:27.568454+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Organovo issues ~3M shares via warrant exercises and ATM sales, raising ~$2.3M

## Summary
- Issued 2,967,144 shares of common stock from warrant exercises and at-the-market sales.
- Gross proceeds expected to be approximately $2.3 million, before fees and commissions.
- After issuance, total outstanding shares are 20,421,617.
- Warrant shares registered under an effective shelf registration statement (May 8, 2024).

## SEC filing metadata
- accession: 0000950170-25-034181
- form_type: 8-K
- ticker: VIVS
- cik: 0001497253
- company_name: VivoSim Labs, INC.
- filed_at: 2025-03-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1497253/000095017025034181/0000950170-25-034181-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1497253/000095017025034181/onvo-20250306.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-034181
- JSON: https://secwatch.observer/filing/0000950170-25-034181.json
- Plain text: https://secwatch.observer/filing/0000950170-25-034181.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.